Systematic functional characterization of candidate causal genes for type 2 diabetes risk variants

Diabetes

Volumn 65, Issue 12, 2016, Pages 3805-3811

  Thomsen, Soren K ^a   Ceroni, Alessandro ^b   Van De Bunt, Martijn ^a,b   Burrows, Carla ^a   Barrett, Amy ^a   Scharfmann, Raphael ^c   Ebner, Daniel ^b   McCarthy, Mark I ^a,b,d   Gloyn, Anna L ^a,b,d  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c INSTITUT COCHIN   (France)

^d NIHR OXFORD BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR; ARL15 PROTEIN, HUMAN; PROTEIN INHIBITOR OF ACTIVATED STAT; THADA PROTEIN, HUMAN; TUMOR PROTEIN; ZMIZ2 PROTEIN, HUMAN;

ARL15 GENE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; FEASIBILITY STUDY; FOLLOW UP; GENE FUNCTION; GENE LOCUS; GENE SILENCING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INSULIN RELEASE; MONOGENIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; THADA GENE; ZMIZ1 GENE; CELL LINE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; PANCREAS ISLET; RISK FACTOR; SECRETION (PROCESS);

ADP-RIBOSYLATION FACTORS; CELL LINE; DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; NEOPLASM PROTEINS; PROTEIN INHIBITORS OF ACTIVATED STAT; RISK FACTORS;

EID: 85000869994     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db16-0361     Document Type: Article

References (25)

1. Ali O. Genetics of type 2 diabetes. World J Diabetes 2013;4:114-123.
2. Prasad RB, Groop L. Genetics of type 2 diabetes-pitfalls and possibilities. Genes (Basel) 2015;6:87-123.
3. Dimas AS, Lagou V, Barker A, et al.; MAGIC Investigators. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2014;63:2158-2171.
4. Thomsen SK, Gloyn AL. The pancreatic b cell: Recent insights from human genetics. Trends Endocrinol Metab 2014;25:425-434.
5. Fadista J, Vikman P, Laakso EO, et al. Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism. Proc Natl Acad Sci U S A 2014;111:13924-13929.
6. van de Bunt M, Manning Fox JE, Dai X, et al. Transcript expression data from human islets links regulatory signals from genome-wide association studies for type 2 diabetes and glycemic traits to their downstream effectors. PLoS Genet 2015;11:e1005694.
7. Burns SM, Vetere A, Walpita D, et al. High-Throughput luminescent reporter of insulin secretion for discovering regulators of pancreatic beta-cell function. Cell Metab 2015;21:126-137.
8. Ku GM, Pappalardo Z, Luo CC, German MS, McManus MT. An siRNA screen in pancreatic beta cells reveals a role for Gpr27 in insulin production. PLoS Genet 2012;8:e1002449.
9. Wu W, Shang J, Feng Y, et al. Identification of glucose-dependent insulin secretion targets in pancreatic beta cells by combining defined-mechanism compound library screening and siRNA gene silencing. J Biomol Screen 2008;13: 128-134.
10. Lee JA, Chu S, Willard FS, et al. Open innovation for phenotypic drug discovery: The PD2 assay panel. J Biomol Screen 2011;16:588-602.
11. Walpita D, Hasaka T, Spoonamore J, et al. A human islet cell culture system for high-Throughput screening. J Biomol Screen 2012;17:509-518.
12. Ravassard P, Hazhouz Y, Pechberty S, et al. A genetically engineered human pancreatic b cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 2011;121:3589-3597.
13. Weir GC, Bonner-Weir S. Finally! A human pancreatic b cell line. J Clin Invest 2011;121:3395-3397.
14. Andersson LE, Valtat B, Bagge A, et al. Characterization of stimulussecretion coupling in the human pancreatic EndoC-bH1 beta cell line. PLoS One 2015;10:e0120879.
15. Krishnan K, Ma Z, Björklund A, Islam MS. Calcium signaling in a genetically engineered human pancreatic b-cell line. Pancreas 2015;44:773-777.
16. Gurgul-Convey E, Kaminski MT, Lenzen S. Physiological characterization of the human EndoC-bH1 b-cell line. Biochem Biophys Res Commun 2015;464: 13-19.
17. Pal A, Potjer TP, Thomsen SK, et al. Loss-of-function mutations in the cellcycle control gene CDKN2A impact on glucose homeostasis in humans. Diabetes 2016;65:527-533.
18. Nica AC, Ongen H, Irminger JC, et al. Cell-Type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res 2013;23: 1554-1562.
19. Shields BM, Hicks S, Shepherd MH, Colclough K, Hattersley AT, Ellard S. Maturity-onset diabetes of the young (MODY): how many cases are we missing? Diabetologia 2010;53:2504-2508.
20. Pearson ER, Boj SF, Steele AM, et al. Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 2007;4:e118.
21. Glaser B. Type 2 diabetes: hypoinsulinism, hyperinsulinism, or both? PLoS Med 2007;4:e148.
22. Rahman SA, Nessa A, Hussain K. Molecular mechanisms of congenital hyperinsulinism. J Mol Endocrinol 2015;54:R119-R129.
23. Pasquali L, Gaulton KJ, Rodríguez-Seguí SA, et al. Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-Associated variants. Nat Genet 2014;46: 136-143.
24. Simonis-Bik AM, Nijpels G, van Haeften TW, et al. Gene variants in the novel type 2 diabetes loci CDC123/CAMK1D, THADA, ADAMTS9, BCL11A, and MTNR1B affect different aspects of pancreatic beta-cell function. Diabetes 2010;59:293- 301.
25. Parikh H, Lyssenko V, Groop LC. Prioritizing genes for follow-up from genome wide association studies using information on gene expression in tissues relevant for type 2 diabetes mellitus. BMC Med Genomics 2009;2:72.